AMGN - AMGEN INC
265.86
-6.190 -2.328%
Share volume: 3,326,222
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$272.05
-6.19
-0.02%
Summary score
66%
Profitability
86%
Dept financing
44%
Liquidity
47%
Performance
56%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
18.97%
Return on assets
3.05%
Return on sales
29.08%
Return on invested capital
5.17%
Total debt ratio
92.73%
Debt ratio change over timeo
21.88%
Current Ratio
1.72%
Quick Ratio
1.37%
Cash Position Ratio
0.83%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
2.68%
Return on sales
21.68%
Return on invested capital
0%
Total debt ratio
92.96%
Debt ratio change over timeo
0%
Current Ratio
1.25%
Quick Ratio
0.92%
Cash Position Ratio
0.44%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
3.02%
Return on sales
14.46%
Return on invested capital
0%
Total debt ratio
93.05%
Debt ratio change over time
0%
Current Ratio
1.17%
Quick Ratio
0.88%
Cash Position Ratio
0.38%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
491.28%
Return on assets
-5.9%
Return on sales
822.47%
Return on invested capital
76.49%
Total debt ratio
2187.51%
Debt ratio change over time
21.88%
Current Ratio
38.77%
Quick Ratio
31.14%
Cash Position Ratio
17.85%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AMGN | GILD | BNTX | BIIB |
|---|---|---|---|---|
| Return on equity | 18.97% | 6.3% | 14.13% | 4.9% |
| Return on assets | 3.05% | 3.04% | 13.28% | 2.27% |
| Return on sales | 29.08% | 27.81% | 1.7% | 22.73% |
| Return on invested capital | 5.17% | 3.5% | -46.9% | 4.81% |
| Profitability | 81% | 55% | 45% | 54% |
| Total debt ratio | 92.73% | 66.91% | 19.17% | 46.96% |
| Debt ratio change over time | 21.88% | 144.36% | -1.07% | 14.72% |
| Dept financing | 29% | 43% | 5% | 15% |
| Current Ratio | 1.25% | 1.34% | 0% | 1.58% |
| Quick Ratio | 0.92% | 1.18% | 0% | 1.05% |
| Cash Position Ratio | 0.44% | 0.54% | 0% | 0.46% |
| Liquididy | 16% | 12% | 75% | 17% |
| Short-term ratios | AMGN | GILD | BNTX | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 2.68% | 3.48% | 0% | 1.89% |
| Return on sales | 21.68% | 28.93% | 0% | 21.33% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 88% | 50% | 0% | 32% |
| Total debt ratio | 92.96% | 66.32% | 0% | 40.7% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 18% | 0% | 11% |
| Current Ratio | 1.25% | 1.34% | 0% | 1.58% |
| Quick Ratio | 0.92% | 1.18% | 0% | 1.05% |
| Cash Position Ratio | 0.44% | 0.54% | 0% | 0.46% |
| Liquididy | 60% | 71% | 0% | 69% |
